Elekta Ab Class B · OMXSTO:EKTA_B
Elekta Ab Class B — Q1 2024/25 Earnings Presentation
21 slides from Elekta Ab Class B's earnings presentation, Aug 28, 2024
Slide 1: Further actions to improve profitability
Further actions to improve profitability Q1 report 2024/25 Gustaf Salford, President and CEO Tobias Hägglöv, CFO Aug 28, 2024 Restricted Information and Basic Personal Data
Slide 2: Important information
Important information This presentation includes forward-looking statements including, but not limited to, statements relating to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future event
Slide 3: Business Overview
Business Overview Gustaf Salford President and CEO Restricted Information and Basic Personal Data
Slide 4: Q1 – key takeaways
Q1 – key takeaways Net sales 1% – increase in constant exchange rates, strong sales development in the U.S. Adj. gross margin 37.8% (41.6%) – YoY decline. Sequential increase supported by an improved service margin Adj. EBIT margin 7.4% (11.2%) – lower gross margin, cost-reduction initiatives in pla
Slide 5: Sales development by region
Sales development by region Americas – increase of 16%1 • Installations in the U.S. showing strong development EMEA • Healthy growth in Canada and Mexico APAC – increase of 3%1 Americas 32% 35% • Sales decline in China driven by the ongoing (28%) (39%) anti-corruption campaign Share APAC • Excluding
Slide 6: Delivering on our ACCESS 2025 strategy in Q1
Delivering on our ACCESS 2025 strategy in Q1 Drive adoption | Elekta receives USD 64 million order for linacs and Gamma Knife system in Mexico • The Hospital Angeles Health System hospital network comprises 27 hospitals nationwide, each offering state-of-the-art medical facilities and a wide range o
Slide 7: Accelerating innovation – adaptive across our portfolio
Accelerating innovation – adaptive across our portfolio 1 *Elekta Evo is not available in all markets Non-Confidential Information and Basic Personal Data
Slide 8: Elekta Evo
Elekta Evo Driving adaptive CT-guided treatments • Online adaptive and easily upgradeable • Iris with high-definition AI enhanced imaging • Well received among customers − Clinical needs and elevating personalized care − Increased productivity Non-Confidential Information and Basic Personal Data
Slide 9: Financial Overview
Financial Overview Tobias Hägglöv CFO Restricted Information and Basic Personal Data
Slide 10: Financial update Q1 24/25
Financial update Q1 24/25 Net sales increased by 1%1 (SEK M) Q1 24/25 Q1 23/24 Q4 23/24 • Solid Service growth of 5% Net sales 3,825 3,828 5,023 • Solutions declined driven by Europe and China Solutions 1,915 1,995 3,060 Service 1,909 1,833 1,963 Adj. gross margin of 37.8% (41.6%) COGS2 -2,380 -2,23
Slide 11: Q1 cash flow after continuous investments
Q1 cash flow after continuous investments (SEK M) Q1 24/25 Q1 23/24 RTM 2023/24 22/23 23/24 24/25 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 SEK M EBITDA 522 693 3,018 3,189 1% Taxes, interest net and other -82 -195 -396 -507 -2% -4% -3% -4% -5% Change in NWC -933 -1,049 -104 -220 -6% -6% -8% Cash flow from oper
Slide 12: Rolling twelve months operational cash conversion
Rolling twelve months operational cash conversion SEK M 100% 83% 3,000Operational cash flow 80% • SEK 2,519 M - SEK 908 M higher compared to last year 2,500 Target >70% 2,000 60% 55% EBITDA 1,500• SEK 3,018 M – SEK 107 M higher compared to last year 40% 1,000 20% Operational cash conversion 500 1,61
Slide 13: Book-to-bill ratio in Q1 and order reporting going forward
Book-to-bill ratio in Q1 and order reporting going forward Book-to-bill ratio The current regional order reporting is challenging to use in forecasting future sales • Larger deals leading to volatility in quarterly order growth not 1.10 (1.00) tied to sales growth Q1 24/25 • Timing – depends on fact
Slide 14: Outlook
Outlook Gustaf Salford President and CEO Restricted Information and Basic Personal Data
Slide 15: Outlook
Outlook First half 24/25 First half of 24/25 to be weaker compared to last year Sales & profitability to pick up during the second half of the year Second half 24/25 as a result of new product launches and productivity measures Net sales for Elekta are expected to grow by mid-single digit for Full y
Slide 16: Summary
Summary Gustaf Salford President and CEO Restricted Information and Basic Personal Data
Slide 17: Summary
Summary • Net sales growth of 1% in constant exchange rates and sequential improvement in adjusted gross margin of 120 basis points • Customer win – Hospital Angeles Health System, Mexico • Further actions to improve profitability – price increases, product launches and efficiency measures Drive for
Slide 18: Financial calendar
Financial calendar Annual General Meeting 2024 Sep 5, 2024 Interim report, Q2 Aug-Oct 2024/25 Nov 27, 2024 Interim report, Q3 Nov-Jan 2024/25 Feb 21, 2025 Interim report, Q4 Feb-Apr 2024/25 May 28, 2025 Further questions Tobias Hägglöv Peter Nyquist CFO Head of Investor Relations +46 76 107 4799 +46
Slide 19: Q&A
Q&A Restricted Information and Basic Personal Data
Slide 20: We don’t just build technology, we build hope
We don’t just build technology, we build hope Restricted Information and Basic Personal Data
Slide 21: Restricted Information and Basic Personal Data
Restricted Information and Basic Personal Data